Express News | CureVac : Deutsche Bank Cuts Target Price to $5 From $6.5

ReutersMay 31 02:21 ET

Third Human Bird Flu Case Found in U.S.

Seeking AlphaMay 30 13:46 ET

CureVac Launches Phase 2 Study for Influenza Vaccine

TipRanksMay 28 18:01 ET

Express News | CureVac Has Dosed The First Participant In Phase 2 Study Of The Multivalent Seasonal Influenza Vaccine Candidate Developed In Collaboration With GSK Against Influenza B Strain

BenzingaMay 28 07:17 ET

Express News | CureVac NV Says CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration With GSK

ReutersMay 28 07:01 ET

CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Yahoo FinanceMay 26 09:13 ET